Cite

HARVARD Citation

    Demirtas, A. et al. (2011). Assessment of the Effects of Zoledronic Acid Therapy on Bone Metabolic Indicators in Hormone-Resistant Prostate Cancer Patients with Bone Metastatasis. ISRN urology. p. . [Online]. 
  
Back to record